Шаблоны LeoTheme для Joomla.
GavickPro Joomla шаблоны

December 2015

Volume 1 Issue 3

 ________________________________________________________________________________________________

Research Article

Evaluation of Commercially Available Multivalent Modified-Live Viral Vaccines on Health and Performance in Feedlot Cattle

D.L. Step DVM, DACVIM, Clinton R. Krehbiel PhD, Cody Hixon MS, Mitchell R. Blanding DVM, Douglas R. Hilbig DVM, Victor S. Cortese DVM, PhD, DABVP*, Thomas H. Short PhD

Bovine respiratory disease complex (BRD) continues to be the single most costly loss associated with commercial beef production in the United States, accounting for 1,0555,000 animals lost in 2010 valued at $643 million. Bovine respiratory disease is the result of a combination of pathogenic microorganisms infecting the host animal and stress. Generally, the most severe cases begin with stress and an initial viral respiratory infection leading to a compromised immune system that allows for bacterial colonization in the lower respiratory tract from pathogens such as Mannheimia haemolytica or Pasturella multocida.

                                                                                                                                                                    Download PDF Full text

________________________________________________________________________________________________

 Research Article

Gastrointestinal Events Associated with Ipilimumab, Pazopanib, Anti PD1- Antibody and Their Management: Single and Combination Therapies

Timothy Allen, MD, Ph.D*, Giridhar M.N.V, MD,MBA*, Ghazaleh Shoja E Razavi MD

Immunotherapy of cancer has made significant advances in the past few years mainly due to the improved understanding of underlying principles of tumor pathology and immunology. Currently many malignancies are being treated by immunotherapy. Including malignant melanoma, advanced renal cell carcinoma (RCC), Non-small cell lung cancer, and prostate cancer. In these malignancies targeted therapies like multi kinase inhibitors also play an important role. These therapies are not without significant adverse events.

 

                                                                                                                                                                    Download PDF Full text

________________________________________________________________________________________________

 Research Article

Encapsulation of Allergens into Chitosan-Alginate Nanoparticles Prevents IgE Binding

E. Kashirina, P. Reshetov, L. Alekseeva, V. Berzhets, D. Ryazantsev, V. Zubov, D. Chudakov, and E. Svirshchevskaya*

Allergens used for allergen specific immunotherapy (ASIT) can induce side effects due to the binding of IgE immobilized on mast cells to allergens. To prevent IgE binding, recombinant allergens from house dust mites (HDM) Dermatophagoides farinae Der f 2 or Aspergillus fumigatus (AF) fungi Asp f 3 were encapsulated into nanoparticles (NPs) developed from biodegradable polymers chitosan and alginate.

                                                                                                                                                                    Download PDF Full text

 

 

 

 

Contact Us:
9600 GREAT HILLS
TRAIL # 150 W
AUSTIN, TEXAS
78759 ( TRAVIS COUNTY)
E-mail : info@jacobspublishers.com
Phone : 512-400-0398